Start with its own history
At 7.60×, BDXB is 79.8% below its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
7.60×
79.8% belowthe 7-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 7.60 for every 1 of reported earnings per share.
Annual period-end data · 7 observations
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2026 | 43.55× | +72.8% |
| Sep 30, 2025 | 25.20× | -21.8% |
| Sep 30, 2024 | 32.23× | -21.2% |
| Sep 30, 2023 | 40.90× | +38.4% |
| Sep 30, 2022 | 29.54× | +8.4% |
| Sep 30, 2021 | 27.25× | -58.0% |
| Sep 30, 2020 | 64.89× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
BDXB This stockBecton, Dickinson and Company | 7.60× |
RVTYRevvity, Inc. | 64.26× |
SWAVShockWave Medical, Inc. | 83.48× |
ITCIIntra-Cellular Therapies, Inc. | N/M |
KRTXKaruna Therapeutics, Inc. | N/M |
CTLTCatalent, Inc. | N/M |
WBAWalgreens Boots Alliance, Inc. | N/M |
ABMDAbiomed, Inc. | 127.01× |
OSHOak Street Health, Inc. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 7.60×, BDXB is 79.8% below its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 3 positive peer ratios above is 83.48×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("BDXB", "PE Ratio", "LQ")Share price 48.16 ÷ EPS 6.334 = 7.60×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.